QIAGEN NV (QGEN)
40.65
+0.20
(+0.49%)
USD |
NYSE |
Mar 19, 16:00
40.65
0.00 (0.00%)
After-Hours: 20:00
QIAGEN Market Cap : 8.374B for March 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InflaRx NV | 61.62M |
| CDT Equity, Inc. | 1.110M |
| LENZ Therapeutics, Inc. | 359.52M |
| Liminatus Pharma, Inc. | 5.432M |
| Oruka Therapeutics, Inc. | 1.923B |
Market Cap Related Metrics
| PE Ratio | 19.89 |
| PS Ratio | 4.044 |
| PEG Ratio | 0.0475 |
| Price to Book Value | 2.216 |
| Price to Free Cash Flow | 18.90 |
| Price | 40.65 |
| Earnings Yield | 5.03% |
| PEGY Ratio | 0.0464 |
| Operating PE Ratio | 16.20 |